UiPath Inc. (PATH)

UiPath pairs a fortress balance sheet — about $1.4 billion in cash and marketable securities, no debt, Altman Z-Score near 5.1, Piotroski score 6 — with a genuine earnings inflection: five straight quarters of GAAP operating profit, operating cash flow of $371 million in fiscal 2026, and a free-cash-flow yield near 5%. The catch: fiscal 2026 headline profit was lifted by a one-time $181.7 million deferred-tax valuation-allowance release, growth has settled to the low-teens (fiscal 2027 revenue guided to ~$1.79 billion, +11%), and insiders including the CEO's entity are persistent sellers. Strong quality with mixed growth and recurring-earnings valuation — a watchlist-grade software name.

Post-earnings media flow turned sharply negative — the Q2 FY27 revenue beat and raised FY27 guidance were overshadowed by a guided Q3 slowdown and AI-competition fears (stock −14–17% on 2026-09-04), and the in-window sell-side cluster (BofA Underperform at $15, price-target hikes with no Buy rating) remains under digestion. The sentiment delta is a determinate item-level deterioration (moderate confidence) from a constructive July–August baseline, and a moderate red-flag cap applies for sharply deteriorating sentiment with no offsetting bullish catalyst.

PATH sits at $13.39, below its SMA20 (15.80), SMA50 (14.35), EMA9 (14.25) and EMA21 (14.92) after a two-week post-earnings slide, with MACD below zero and falling (line -0.39, histogram -0.44) and ADX at 26.08 confirming a live down trend; the only constructive anchor is the SMA200 at 12.91, which still holds below price. RSI 38.96 and Williams %R -97.76 show stretched short-term momentum, but no reversal trigger is confirmed. The chart scores 2 (weak bearish, bounce-only). The action is Do Nothing on the qualitative override: qualitativeScore 2 is below the required floor of 3, and no chart pattern overrides that.